{"text_format":"3","workbook":"xlsx","n_sheets":1,"sheets":["Sheet1"],"read":"whole","date_system":"1900"}

{"sheet":"Sheet1","index":0,"n_rows":19,"n_cols":5,"rows_kept":19,"merged":[[0,0,0,4],[18,0,19,4]]}
["Table 2. Cox proportional hazards regression model showing the association of variables with disease-free survival"]
[null,"Univariable",null,"Multivariable"]
["Variable","HR(95%CI)","P value","HR(95%CI)","P value"]
["Factors selected"]
["Age, >65 vs. ≤65","1.908(1.286-2.830)",{"v":0.0013,"d":"0.001"},"1.770(1.160-2.702)",{"v":0.0081,"d":"0.008"}]
["Hb, >100 vs. ≤100","0.626(0.465-0.844)",{"v":0.00228,"d":"0.002"},"0.634(0.462-0.870)",0.005]
["albumin, >35 vs. ≤35","0.433(0.336-0.557)","<0.001","0.473(0.363-0.615)","<0.001"]
["Cyto/molecular genetic risk group"]
["  intermediate vs. favorable","1.546(1.086-2.201)",{"v":0.0161,"d":"0.016"},"1.614(1.128-2.309)",{"v":0.0008,"d":"0.001"}]
["  poor vs. favorable","2.247(1.510-3.345)","<0.001","2.459(1.645-3.676)","<0.001"]
["allo-HSCT, Yes vs. No","0.316(0.219-0.457)","<0.001","0.341(0.234-0.497)","<0.001"]
["Factors not selected"]
["Sex, male vs. female","1.063(0.828-1.366)",0.632]
["WBC, >40 vs. ≤40","1.442(1.112-1.871)",{"v":0.0058,"d":"0.006"},"1.296(0.984-1.706)",0.065]
["Platelet, >50 vs. ≤50","0.839(0.649-1.083)",0.178]
["PB blast, >65 vs. ≤65","1.315(1.023-1.692)",0.033,"1.042(0.782-1.388)",{"v":0.7809,"d":"0.781"}]
["BM blast, >50 vs. ≤50","1.218(0.924-1.607)",0.161]
[]
["Abbreviations: HR, hazard ratio; CI, confidence intervals; Hb, hemoglobin; allo-HSCT, allogeneic hematopoietic stem cell transplantation; WBC, white blood cell; PB, peripheral blood; BM, bone marrow."]